Selected article for: "cross reactivity and important role"
Author: Liu, William J.; Zhao, Min; Liu, Kefang; Xu, Kun; Wong, Gary; Tan, Wenjie; Gao, George F.
Title: T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV
  • Cord-id: wh9vvgv2
  • Document date: 2016_11_11
    • ID: wh9vvgv2
    Snippet: Over 12 years have elapsed since severe acute respiratory syndrome (SARS) triggered the first global alert for coronavirus infections. Virus transmission in humans was quickly halted by public health measures and human infections of SARS coronavirus (SARS-CoV) have not been observed since. However, other coronaviruses still pose a continuous threat to human health, as exemplified by the recent emergence of Middle East respiratory syndrome (MERS) in humans. The work on SARS-CoV widens our knowled
    Document: Over 12 years have elapsed since severe acute respiratory syndrome (SARS) triggered the first global alert for coronavirus infections. Virus transmission in humans was quickly halted by public health measures and human infections of SARS coronavirus (SARS-CoV) have not been observed since. However, other coronaviruses still pose a continuous threat to human health, as exemplified by the recent emergence of Middle East respiratory syndrome (MERS) in humans. The work on SARS-CoV widens our knowledge on the epidemiology, pathophysiology and immunology of coronaviruses and may shed light on MERS coronavirus (MERS-CoV). It has been confirmed that T-cell immunity plays an important role in recovery from SARS-CoV infection. Herein, we summarize T-cell immunological studies of SARS-CoV and discuss the potential cross-reactivity of the SARS-CoV-specific immunity against MERS-CoV, which may provide useful recommendations for the development of broad-spectrum vaccines against coronavirus infections.

    Search related documents:
    Co phrase search for related documents
    • abundant protein and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • accession genbank and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4
    • acute lung failure and adaptive immunity: 1
    • acute lung injury and adaptive immunity: 1, 2, 3, 4, 5, 6
    • acute lung injury and long term protection: 1
    • acute lung injury and longitudinal study: 1
    • acute respiratory illness and adaptive immunity: 1, 2, 3, 4
    • acute respiratory illness and longitudinal study: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute sars cov respiratory syndrome coronavirus and adaptive immunity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute sars cov respiratory syndrome coronavirus and long term memory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute sars cov respiratory syndrome coronavirus and long term protection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • acute sars cov respiratory syndrome coronavirus and longitudinal study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • adaptive immunity and long term memory: 1, 2
    • adaptive immunity and long term protection: 1, 2
    • adaptive immunity and longitudinal study: 1